Sage Therapeutics Statistics
Total Valuation
SAGE has a market cap or net worth of $651.17 million. The enterprise value is -$65.37 million.
Market Cap | 651.17M |
Enterprise Value | -65.37M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
Earnings Date | Aug 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SAGE has 60.18 million shares outstanding. The number of shares has increased by 0.77% in one year.
Shares Outstanding | 60.18M |
Shares Change (YoY) | +0.77% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 11.94% |
Owned by Institutions (%) | 92.89% |
Float | 47.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.15 |
Forward PS | 12.04 |
PB Ratio | 0.92 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22, with a Debt / Equity ratio of 0.00.
Current Ratio | 12.22 |
Quick Ratio | 11.82 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.90% and return on invested capital (ROIC) is -76.44%.
Return on Equity (ROE) | -60.90% |
Return on Assets (ROA) | -54.70% |
Return on Capital (ROIC) | -76.44% |
Revenue Per Employee | $186,990 |
Profits Per Employee | -$1.03M |
Employee Count | 487 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.54% in the last 52 weeks. The beta is 0.92, so SAGE's price volatility has been similar to the market average.
Beta (5Y) | 0.92 |
52-Week Price Change | -77.54% |
50-Day Moving Average | 11.85 |
200-Day Moving Average | 18.54 |
Relative Strength Index (RSI) | 44.50 |
Average Volume (20 Days) | 1,514,184 |
Short Selling Information
The latest short interest is 7.80 million, so 12.96% of the outstanding shares have been sold short.
Short Interest | 7.80M |
Short Previous Month | 6.95M |
Short % of Shares Out | 12.96% |
Short % of Float | 16.41% |
Short Ratio (days to cover) | 5.38 |
Income Statement
In the last 12 months, SAGE had revenue of $91.06 million and -$503.14 million in losses. Loss per share was -$8.39.
Revenue | 91.06M |
Gross Profit | 87.87M |
Operating Income | -542.06M |
Pretax Income | -503.14M |
Net Income | -503.14M |
EBITDA | -501.74M |
EBIT | -503.14M |
Loss Per Share | -$8.39 |
Balance Sheet
The company has $719.85 million in cash and $3.31 million in debt, giving a net cash position of $716.54 million or $11.91 per share.
Cash & Cash Equivalents | 719.85M |
Total Debt | 3.31M |
Net Cash | 716.54M |
Net Cash Per Share | $11.91 |
Equity (Book Value) | 705.80M |
Book Value Per Share | 11.73 |
Working Capital | 693.64M |
Cash Flow
In the last 12 months, operating cash flow was -$424.74 million and capital expenditures -$328,000, giving a free cash flow of -$425.06 million.
Operating Cash Flow | -424.74M |
Capital Expenditures | -328,000 |
Free Cash Flow | -425.06M |
FCF Per Share | -$7.07 |
Margins
Gross margin is 96.49%, with operating and profit margins of -595.25% and -552.52%.
Gross Margin | 96.49% |
Operating Margin | -595.25% |
Pretax Margin | -552.52% |
Profit Margin | -552.52% |
EBITDA Margin | -550.97% |
EBIT Margin | -552.52% |
FCF Margin | -466.77% |
Dividends & Yields
SAGE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.77% |
Shareholder Yield | -0.77% |
Earnings Yield | -77.27% |
FCF Yield | -65.28% |
Analyst Forecast
The average price target for SAGE is $18.39, which is 69.96% higher than the current price. The consensus rating is "Hold".
Price Target | $18.39 |
Price Target Difference | 69.96% |
Analyst Consensus | Hold |
Analyst Count | 19 |
Revenue Growth Forecast (5Y) | 48.21% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SAGE has an Altman Z-Score of 0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.48 |
Piotroski F-Score | 3 |